BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 8, 2026
Home » Topics » Medical technology, Science

Medical technology, Science
Medical technology, Science RSS Feed RSS

BioWorld MedTech’s Oncology Extra for Nov. 3, 2020

Nov. 3, 2020
By Mark McCarty and Anette Breindl
Keeping you up to date on recent developments in oncology, including: Microfluidic provides model for testing therapies on pancreatic ductal adenocarcinoma; Cutting off AML’s metabolic escape route; NGF: PDAC’s VEGF?; Revving up cisplatin by targeting Rev7.
Read More

BioWorld MedTech’s Cardiology Extra for Nov. 2, 2020

Nov. 2, 2020
By Liz Hollis
Keeping you up to date on recent developments in cardiology, including: Mobile smartphone tech tied to better clinical outcomes for OHCA; Lung scans for earlier COVID-19 detection; Cholesterol meds affects the organs differently.
Read More
Mouse DNA illustration

ENA 2020: Progress in cancer research can come one mouse at a time, study suggests

Oct. 30, 2020
By Anette Breindl
Under the right circumstances, a single mouse can be as good as a group of eight or 10 animals in predicting whether a tumor will respond to a drug, researchers reported at the 2020 EORTC-NCI-AACR (ENA) Molecular Targets meeting on Saturday. The single-animal approach “allows incorporation of more tumor models within the same resource constraints,” Peter Houghton told reporters at a press conference previewing ENA highlights.
Read More

BioWorld MedTech’s Neurology Extra for Oct. 30, 2020

Oct. 30, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Software developed to objectively calculate white matter hyperintensities; CSF biomarkers point to underlying cause of neural damage in COVID-19; Scientists discover how cryptochrome mutation leads to sleep disorder; Physical labor significantly increases the risk of dementia.
Read More
VEXAS illustration

ASHG 2020: New inflammatory disease, and maybe, a new classification system

Oct. 29, 2020
By Anette Breindl
Anthony Wynshaw-Boris, professor and chair of the department of genetics and genome sciences at Case Western Reserve University School of Medicine, set a positive tone in his opening talk at the 2020 annual meeting of the American Society of Human Genetics (ASHG). "This is guaranteed to be the best-ever virtual ASHG annual meeting," he told the audience. The opening plenary abstract session, for one, did not disappoint. It began with the definition of a new disease, identified through a new approach, and possibly leading to a new way to think about rheumatic diseases.
Read More

BioWorld MedTech’s Diagnostics Extra for Oct. 29, 2020

Oct. 29, 2020
By Meg Bryant
Keeping you up to date on recent developments in diagnostics, including: A case for pooled testing of SARS-CoV-2; FIT as effective as colonoscopy in ruling out suspected colorectal cancer; Looking to comparative genomics analysis to explain COVID-19 susceptibility.
Read More

BioWorld MedTech’s Orthopedics Extra for Oct. 28, 2020

Oct. 28, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Younger knee replacement patients more likely to require reoperation; New research predicts whether rheumatoid arthritis patients will respond to treatment; Steroid inhalers/pills for asthma linked to heightened risk of brittle bones and fractures.
Read More

BioWorld MedTech’s Oncology Extra for Oct. 27, 2020

Oct. 27, 2020
By Mark McCarty and Anette Breindl
Keeping you up to date on recent developments in oncology, including: Study hints cystectomy not the only answer to muscle-invasive bladder cancer; Drugging resistant androgen receptors; ‘Don’t Eat Me’ signal doubles as ‘Don’t Find Me’; New algorithm may aid in oncology drug development.
Read More

BioWorld MedTech’s Cardiology Extra for Oct. 26, 2020

Oct. 26, 2020
By Liz Hollis
Keeping you up to date on recent developments in cardiology, including: Monitoring the hearts of breast cancer patients; Cardiamp demonstrates improvement in heart failure patients; Weight-reduction surgery in severely obese patients could ward off second heart attack.
Read More
Kathryn Atkinson, an elderly patient, participating in a smartphone screening test to analyze stroke-like symptoms

AI-based app can diagnose stroke in minutes

Oct. 23, 2020
By Annette Boyle
A new tool for mobile devices can diagnose stroke as accurately as an emergency medicine specialist in just minutes, enabling patients to get brain-saving therapies in time for maximum benefit. According to researchers from Pennsylvania State University and Houston Methodist Hospital, the artificial intelligence (AI)-based tool could counterbalance physician biases, reducing both overuse of CT scans and underdiagnosis of mild and moderate stroke.
Read More
Previous 1 2 … 31 32 33 34 35 36 37 38 39 … 69 70 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 7, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing